Evercore Wealth Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Evercore Wealth Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-375	Closed	–	–	922
2017 Q4	$0	Hold	375	–	–	﹤0.01%	950
2017 Q3	$0	Hold	375	–	–	﹤0.01%	999
2017 Q2	$0	Hold	375	–	–	﹤0.01%	1084
2017 Q1	$0	Hold	375	–	–	﹤0.01%	1085
2016 Q4	$0	Hold	375	–	–	﹤0.01%	1147
2016 Q3	$0	Hold	375	–	–	﹤0.01%	1102
2016 Q2	$0	Hold	375	–	–	﹤0.01%	1079
2016 Q1	$0	Hold	375	–	–	﹤0.01%	1068
2015 Q4	$0	Hold	375	–	–	﹤0.01%	1123
2015 Q3	$0	Hold	375	–	–	﹤0.01%	1122
2015 Q2	$0	Hold	375	–	–	﹤0.01%	1133
2015 Q1	$0	Hold	375	–	–	﹤0.01%	1086
2014 Q4	$0	Hold	375	–	–	﹤0.01%	1052
2014 Q3	$0	Hold	375	–	–	﹤0.01%	1044
2014 Q2	$0	Hold	375	–	–	﹤0.01%	1078
2014 Q1	$0	Hold	375	–	–	﹤0.01%	953
2013 Q4	$0	Hold	375	–	–	﹤0.01%	1065
2013 Q3	$1K	Hold	375	–	–	﹤0.01%	994
2013 Q2	$0	Buy	+375	New	+$659	﹤0.01%	804

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BCM

Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

NGA

New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

Evercore Wealth Management's GCVRZ Position: Q1 2018 in Review

Evercore Wealth Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2018, closing a stake of 375 shares.

Evercore Wealth Management first reported a position in GCVRZ in Q2 2013 and held it in 19 quarters. The position peaked at $1K in Q3 2013. 100 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2018.

Evercore Wealth Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2018 after selling out during the quarter.
Evercore Wealth Management sold 375 Sanofi Contingent Value Rights shares in Q1 2018.
Evercore Wealth Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 19 quarters.
Evercore Wealth Management's Sanofi Contingent Value Rights position peaked at $1K in Q3 2013.
100 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2018.

Based on Evercore Wealth Management's 13F filing for Q1 2018, filed 15 May 2018.